Once a drug is marketed, it leaves the secure and protected scientific environment of clinical trials and is free for consumption by the general public. At this point, most medicines will only have been tested for short-term safety and efficacy on a limited number of carefully selected individuals. A person with drug toxicity has accumulated too much of medication in the bloodstream. Hence, the need of Pharmacovigilance arises which includes, securing the early detection of new adverse reactions or patients subgroups of exceptional sensitivity; and introducing certain measures in order to manage such risks. The field of Patients‟ drug safety has been receiving a great deal of attention since adverse drug reactions are recognized as hazards of drug therapy. In addition, adverse drug reactions have a major impact on public health by imposing a considerable economic burden on patients, societyand the already stretched health care system.
"Sinopsis" puede pertenecer a otra edición de este libro.
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Once a drug is marketed, it leaves the secure and protected scientific environment of clinical trials and is free for consumption by the general public. At this point, most medicines will only have been tested for short-term safety and efficacy on a limited number of carefully selected individuals. A person with drug toxicity has accumulated too much of medication in the bloodstream. Hence, the need of Pharmacovigilance arises which includes, securing the early detection of new adverse reactions or patients subgroups of exceptional sensitivity; and introducing certain measures in order to manage such risks. The field of Patients drug safety has been receiving a great deal of attention since adverse drug reactions are recognized as hazards of drug therapy. In addition, adverse drug reactions have a major impact on public health by imposing a considerable economic burden on patients, societyand the already stretched health care system. 240 pp. Englisch. Nº de ref. del artículo: 9786200321121
Cantidad disponible: 2 disponibles
Librería: Books Puddle, New York, NY, Estados Unidos de America
Condición: New. Nº de ref. del artículo: 26397285006
Cantidad disponible: 4 disponibles
Librería: moluna, Greven, Alemania
Kartoniert / Broschiert. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Once a drug is marketed, it leaves the secure and protected scientific environment of clinical trials and is free for consumption by the general public. At this point, most medicines will only have been tested for short-term safety and efficacy on a limited. Nº de ref. del artículo: 593855084
Cantidad disponible: Más de 20 disponibles
Librería: Majestic Books, Hounslow, Reino Unido
Condición: New. Print on Demand. Nº de ref. del artículo: 400140625
Cantidad disponible: 4 disponibles
Librería: Biblios, Frankfurt am main, HESSE, Alemania
Condición: New. PRINT ON DEMAND. Nº de ref. del artículo: 18397284996
Cantidad disponible: 4 disponibles
Librería: preigu, Osnabrück, Alemania
Taschenbuch. Condición: Neu. Evaluation of Evidence | Based Pharmacovigilance Study and Clinical Pharmacist Role in Tertiary Care Hospital. | Venkata Rama Rao Nallani (u. a.) | Taschenbuch | Englisch | 2022 | LAP LAMBERT Academic Publishing | EAN 9786200321121 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand. Nº de ref. del artículo: 121661446
Cantidad disponible: 5 disponibles
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Once a drug is marketed, it leaves the secure and protected scientific environment of clinical trials and is free for consumption by the general public. At this point, most medicines will only have been tested for short-term safety and efficacy on a limited number of carefully selected individuals. A person with drug toxicity has accumulated too much of medication in the bloodstream. Hence, the need of Pharmacovigilance arises which includes, securing the early detection of new adverse reactions or patients subgroups of exceptional sensitivity; and introducing certain measures in order to manage such risks. The field of Patients¿ drug safety has been receiving a great deal of attention since adverse drug reactions are recognized as hazards of drug therapy. In addition, adverse drug reactions have a major impact on public health by imposing a considerable economic burden on patients, societyand the already stretched health care system.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 240 pp. Englisch. Nº de ref. del artículo: 9786200321121
Cantidad disponible: 1 disponibles
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Once a drug is marketed, it leaves the secure and protected scientific environment of clinical trials and is free for consumption by the general public. At this point, most medicines will only have been tested for short-term safety and efficacy on a limited number of carefully selected individuals. A person with drug toxicity has accumulated too much of medication in the bloodstream. Hence, the need of Pharmacovigilance arises which includes, securing the early detection of new adverse reactions or patients subgroups of exceptional sensitivity; and introducing certain measures in order to manage such risks. The field of Patients drug safety has been receiving a great deal of attention since adverse drug reactions are recognized as hazards of drug therapy. In addition, adverse drug reactions have a major impact on public health by imposing a considerable economic burden on patients, societyand the already stretched health care system. Nº de ref. del artículo: 9786200321121
Cantidad disponible: 1 disponibles